GSK | BiotechTV

top of page

Jefferies London: Chief Scientific Officer Tony Wood covers the latest highlights in GSK's pipeline, including oncology, respiratory, and inflammation

He mentions momelotinib, Blenrep, B7-H3, depemokimab, efimosfermin, IL-33, TSLP, and more. Plus, GSK's dealmaking strategy. Coverage brought to you by

Company News

13 hours ago

GSK's Emma Walmsley on the company's pipeline, business development, AI, UK life sciences, and more

In a wide ranging interview, Emma Walmsley discusses GSK's R&D activities in its four main areas of focus.

Company News

Apr 30, 2024

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.

Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.

Learn more about Evaluate

bottom of page

Jefferies London: Chief Scientific Officer Tony Wood covers the latest highlights in GSK's pipeline, including oncology, respiratory, and inflammation

GSK's Emma Walmsley on the company's pipeline, business development, AI, UK life sciences, and more

Follow BiotechTV

Sponsors

Sponsor Spotlight